Table 1.
Study Characteristics
Agent and Study | No. of Patients in Current Analysis | Breast Cancer History (No. of patients) |
Tamoxifen (No. of patients) |
||||
---|---|---|---|---|---|---|---|
Yes | No | Unknown | Yes | No | Unknown | ||
Venlafaxine | |||||||
Loprinzi et al4 | 191 | 191 | 0 | 0 | 134 | 57 | 0 |
Fluoxetine | |||||||
Loprinzi et al5 | 68 | 68 | 0 | 0 | 38 | 30 | 0 |
Paroxetine | |||||||
Stearns et al7 | 142 | 12 | 130 | 0 | 5 | 137 | 0 |
Stearns et al6 | 117 | 97 | 20 | 0 | 69 | 40 | 8 |
Sertraline | |||||||
Kimmick et al8 | 49 | 49 | 0 | 0 | 49 | 0 | 0 |
Gordon et al11 | 91 | 0 | 91 | 0 | 0 | 91 | 0 |
Grady et al12 | 90 | 0 | 90 | 0 | 0 | 90 | 0 |
Gabapentin | |||||||
Pandya et al16 | 358 | 358 | 0 | 0 | 252 | 94 | 12 |
Guttuso et al15 | 54 | 0 | 54 | 0 | 0 | 54 | 0 |
Reddy et al17 | 38 | 0 | 38 | 0 | 0 | 38 | 0 |